ROBERT HOFFMAN Insider Trading
Get free email notifications about insider trading for ROBERT HOFFMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT HOFFMAN. ROBERT HOFFMAN is a CFO & SVP, Finance in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and a CFO & CAO in ARENA PHARMACEUTICALS INC ($ARNA) and a SVP, Finance and CFO in ARENA PHARMACEUTICALS INC ($ARNA) and a VP, Finance in ARENA PHARMACEUTICALS INC ($ARNA) and a VP, Finance & CAO in ARENA PHARMACEUTICALS INC ($ARNA) and a VP, Finance and CFO in ARENA PHARMACEUTICALS INC ($ARNA) and a in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and a Director in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and a Director in CombiMatrix Corp ($CBMX) and a CHIEF FINANCIAL OFFICER in INNOVUS PHARMACEUTICALS, INC. ($INNV) and a Director in Kura Oncology, Inc. ($KURA) and a Director in DelMar Pharmaceuticals, Inc. ($DMPI) and a Director in Aravive, Inc. ($VSAR).
Address: C/O ARENA PHARMACEUTICALS, INC. 6166 NANCY RIDGE DRIVE SAN DIEGO 92121 CA
Companies in which ROBERT HOFFMAN is an Insider
Aravive, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT HOFFMAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 13 2019
$ARAV Market Capitalization: $474.95M
$ARAV Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARENA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT HOFFMAN: SVP, Finance and CFO, VP, Finance and CFO, CFO & CAO, VP, Finance & CAO, VP, Finance
Holdings: 3,382 shares
Current Value: $5,039
Latest Transaction: Oct 02 2012
$ARNA Market Capitalization: $357.67M
$ARNA Previous Close: $1.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CombiMatrix Corp
Industry: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
Position of ROBERT HOFFMAN: Director
Holdings: 6,618 shares
Current Value: $24,156
Latest Transaction: Nov 16 2017
$CBMX Market Capitalization: $9.88M
$CBMX Previous Close: $3.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HERON THERAPEUTICS, INC. /DE/
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT HOFFMAN: CFO & SVP, Finance
Holdings: 1,280 shares
Latest Transaction: Dec 23 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INNOVUS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT HOFFMAN: CHIEF FINANCIAL OFFICER
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 21 2016
$INNV Market Capitalization: $18.88M
$INNV Previous Close: $0.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kintara Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT HOFFMAN: Director
Holdings: 0 shares
Latest Transaction: Sep 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kura Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT HOFFMAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 23 2021
$KURA Market Capitalization: $124.74M
$KURA Previous Close: $6.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MABVAX THERAPEUTICS HOLDINGS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT HOFFMAN:
Holdings: 4,438 shares
Current Value: $13,181
Latest Transaction: May 23 2017
$MBVX Market Capitalization: $18.01M
$MBVX Previous Close: $2.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ROBERT HOFFMAN
Sentiment: All, ARAV, ARNA, CBMX, HRTX, INNV, KTRA, KURA, MBVX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2021 | KURA | Kura Oncology, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | A | 21.54 | 23,000 | 495,420 | 23,000 | |
| Sep 17 2020 | DMPI | Kintara Therapeuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 1.70 | 120,000 | 204,000 | 120,000 | |
| Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 75,000 | |
| Jun 26 2020 | KURA | Kura Oncology, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | A | 17.97 | 23,000 | 413,310 | 23,000 | |
| Dec 23 2019 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | A | 25.02 | 100,000 | 2,502,000 | 100,000 | |
| Sep 13 2019 | ARAV | Aravive, Inc. | HOFFMAN ROBERT | Director | Option Exercise | A | 5.77 | 7,500 | 43,275 | 7,500 | |
| Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.61 | 35,433 | 21,614 | 35,433 |